市場調査レポート

商品コード

1422062

細胞治療市場の機会および予測 (2017-2031年)：治療タイプ・細胞タイプ・製品タイプ・用途・エンドユーザー・地域別

Cell Therapy Market Assessment, By Therapy Type, By Cell Type, By Product, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月07日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 236 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細胞治療の市場規模は、2023年の46億7,000万米ドルから、予測期間中は13.56%のCAGRで推移し、2031年には129億3,000万米ドルに達すると予測されています。

主な促進要因としては、慢性疾患の有病率の上昇、R&D投資の増加、細胞治療技術の絶え間ない進歩、支持的な規制環境、協力的パートナーシップ、用途の拡大などが挙げられます。需要拡大の背景には、世界での慢性疾患の増加があります。こうした疾患が増加す中で、革新的で効果的な治療法に対する需要が高まっており、細胞治療は有望なソリューションとして位置づけられています。

慢性疾患の有病率の上昇

慢性疾患の有病率の上昇は、世界の細胞治療市場にとって重要な推進因子となっています。少なくとも1つの慢性疾患に罹患する50歳以上の人口は大きく増加しており、2020年の7,152万2,000人から、2050年には99.5%増の1億4,266万人に達すると予測されています。この人口動態の変化は、先進的で効果的な治療介入が急務であることを意味しており、その有望な解決策として細胞治療が浮上しています。さらに、複数の疾病に罹患する患者数は2020年の783万400人から、2050年には91.16％増の1,496万8,000人に達すると予測されており、高齢化社会が直面する健康課題の複雑さを浮き彫りにしています。健康負担の増大に対応するため、革新的な細胞治療への需要が高まっており、市場は進化するヘルスケア状況に対応し、慢性疾患管理に的を絞ったソリューションを提供する立場にあります。

政府の取り組み

世界各国の政府は、世界の細胞治療市場の成長を促進するため、大手企業と協力しています。このようなパートナーシップは、政府の支援と専門知識を活用して細胞治療の研究、開発、アクセシビリティを促進することを目的としています。このような協力関係を促進することで、政策立案者はイノベーションを助長する環境を整え、規制当局の承認を加速し、こうした先進的な医療介入の普及を確実なものにしようとしています。政府と主要な業界関係者の間の相乗効果は、ヘルスケアに革命をもたらし、世界的規模で課題に対処する細胞治療の可能性を最大限に実現するという共通のコミットメントを反映しています。

当レポートでは、世界の細胞治療の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
治療タイプ別
- 同種療法
- 自己療法
細胞タイプ別
- 幹細胞
- 非幹細胞
製品別
- 培地、血清、試薬
- 細胞工学製品
- 細胞培養容器
- 細胞治療装置
- システム・ソフトウェア
- その他
用途別
- 心臓血管
- 筋骨格
- 腫瘍
- 皮膚
- その他
エンドユーザー別
- 病院・診療所
- バイオ医薬品およびバイオ技術企業
- 学術研究機関
- その他
地域別
- 北米
- 欧州
- 南米
- アジア太平洋
- 中東・アフリカ
企業別市場シェア

第5章世界の細胞治療市場の見通し：地域別

北米
欧州
南米
アジア太平
中東・アフリカ

第6章市場マッピング

治療タイプ別
細胞タイプ別
製品別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長推進因子
成長抑制因子 (課題・障壁)

第9章規制の枠組み・イノベーション

臨床試験
特許の情勢
規制当局の承認
イノベーション/最新技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (参入5社)
特許分析 (該当する場合)

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Thermo Fisher Scientific Inc.
Merck KGaA
AstraZeneca plc
Astellas Pharma Inc.
Danaher Corporation
Sanofi S.A.
Becton, Dickinson and Company
Lonza Group
Novartis AG
Fresenius Medical Care AG & Co. KGaA
Avantor, Inc.
Bio-Techne Corporation

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 4. Global Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 5. Global Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 6. Global Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 7. Global Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 8. Global Cell Therapy Market Share (%), By Region, 2017-2031F
Figure 9. North America Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 12. North America Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 13. North America Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 14. North America Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 15. North America Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 16. North America Cell Therapy Market Share (%), By Country, 2017-2031F
Figure 17. United States Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 20. United States Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 21. United States Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 22. United States Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 23. United States Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 24. Canada Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 27. Canada Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 28. Canada Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 29. Canada Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 30. Canada Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 31. Mexico Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 34. Mexico Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 35. Mexico Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 36. Mexico Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 38. Europe Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 41. Europe Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 42. Europe Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 43. Europe Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 44. Europe Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 45. Europe Cell Therapy Market Share (%), By Country, 2017-2031F
Figure 46. Germany Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 49. Germany Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 50. Germany Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 51. Germany Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 52. Germany Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 53. France Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 55. France Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 56. France Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 57. France Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 58. France Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 59. France Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 60. Italy Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 63. Italy Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 64. Italy Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 65. Italy Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 66. Italy Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 67. United Kingdom Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 70. United Kingdom Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 71. United Kingdom Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 72. United Kingdom Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 74. Russia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 77. Russia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 78. Russia Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 79. Russia Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 80. Russia Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 81. Netherlands Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 84. Netherlands Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 85. Netherlands Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 86. Netherlands Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 88. Spain Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 91. Spain Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 92. Spain Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 93. Spain Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 94. Spain Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 95. Turkey Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 98. Turkey Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 99. Turkey Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 100. Turkey Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 102. Poland Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 105. Poland Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 106. Poland Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 107. Poland Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 108. Poland Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 109. South America Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 112. South America Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 113. South America Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 114. South America Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 115. South America Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 116. South America Cell Therapy Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 120. Brazil Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 121. Brazil Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 122. Brazil Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 124. Argentina Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 127. Argentina Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 128. Argentina Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 129. Argentina Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 131. Asia-Pacific Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 134. Asia-Pacific Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 135. Asia-Pacific Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 136. Asia-Pacific Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 138. Asia-Pacific Cell Therapy Market Share (%), By Country, 2017-2031F
Figure 139. India Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 141. India Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 142. India Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 143. India Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 144. India Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 145. India Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 146. China Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 148. China Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 149. China Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 150. China Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 151. China Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 152. China Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 153. Japan Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 156. Japan Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 157. Japan Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 158. Japan Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 159. Japan Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 160. Australia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 163. Australia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 164. Australia Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 165. Australia Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 166. Australia Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 167. Vietnam Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 170. Vietnam Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 171. Vietnam Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 172. Vietnam Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 174. South Korea Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 177. South Korea Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 178. South Korea Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 179. South Korea Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 181. Indonesia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 184. Indonesia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 185. Indonesia Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 186. Indonesia Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 188. Philippines Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 191. Philippines Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 192. Philippines Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 193. Philippines Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 195. Middle East & Africa Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 198. Middle East & Africa Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 199. Middle East & Africa Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 200. Middle East & Africa Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 202. Middle East & Africa Cell Therapy Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 206. Saudi Arabia Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 207. Saudi Arabia Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 208. Saudi Arabia Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 210. UAE Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 213. UAE Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 214. UAE Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 215. UAE Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 216. UAE Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 217. South Africa Cell Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Cell Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa Cell Therapy Market Share (%), By Therapy Type, 2017-2031F
Figure 220. South Africa Cell Therapy Market Share (%), By Cell Type, 2017-2031F
Figure 221. South Africa Cell Therapy Market Share (%), By Product, 2017-2031F
Figure 222. South Africa Cell Therapy Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Cell Therapy Market Share (%), By End-users, 2017-2031F
Figure 224. By Therapy Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Cell Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10927

Global cell therapy market size was valued at USD 4.67 billion in 2023, expected to reach USD 12.93 billion in 2031, with a CAGR of 13.56% for the forecast period between 2024 and 2031. Several factors propel the global cell therapy market, creating an exciting and high-potential environment. Key drivers include the rising prevalence of chronic diseases, increasing investments in research and development, continuous advancements in cell therapy technologies, a supportive regulatory environment, collaborative partnerships, and growing applications. A prominent force behind the growing demand is the increasing prevalence of chronic diseases worldwide. As these conditions become more prevalent, there is an increasing demand for innovative and effective treatments, positioning cell therapy as a promising solution.

Pharmaceutical companies and research institutions are investing significant amounts in exploring the vast potential of cell therapies. This financial commitment fosters groundbreaking discoveries and accelerates the development of novel treatments. Advancements in cell therapy technologies are further contributing to this dynamic landscape. Breakthrough technologies such as CRISPR gene editing are enhancing the precision and efficacy of cell therapies, opening new possibilities for therapeutic interventions across various medical domains in global cell therapy market. A supportive regulatory environment acts as a catalyst, streamlining approval processes and encouraging companies to invest in the development of cell-based treatments, boosting the growth of the global cell therapy market. Collaborative partnerships between pharmaceutical/biotech firms, and academic institutions leverage collective strengths, fostering innovation and expediting the commercialization of promising therapies. As cell therapy applications continue to broaden from oncology to neurodegenerative diseases, the global awareness and acceptance of these innovative treatments are on the rise.

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases is a significant catalyst for the global cell therapy market. As the population aged 50 and above faces a staggering increase in the incidence of at least one chronic disease, the numbers are projected to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. The demographic shift signifies an urgent need for advanced and effective therapeutic interventions, with cell therapy emerging as a promising solution. Moreover, the projection of a 91.16% increase in individuals with multimorbidity-from 7.8304 million in 2020 to 14.968 million in 2050, highlights the complexity of health challenges an aging population faces. In response to the growing health burden, the demand for innovative cell therapies is rising, positioning the market to address the evolving healthcare landscape and offer targeted solutions for chronic disease management.

Growing Investments for Developing Modern Cell Therapy Solutions

Leading companies are investing substantially in cell therapy by establishing state-of-the-art manufacturing facilities. The initiative reflects their confidence in cell therapies' potential and is a significant driver for the global cell therapy market. Significant investments in advanced production facilities enable increasing production capacity and scalability, resulting in a more efficient and widespread delivery of cell-based treatments. The proactive approach by major industry players fosters innovation and contributes to the overall growth and maturity of the global cell therapy market, solidifying their position as a transformative force in healthcare.

For instance, in October 2023, Bayer AG revealed its inaugural cell therapy launch facility in Berkeley, California, marking a pivotal step in their global initiative to provide cell therapies to patients. The USD 250 million, 100,000-square-foot facility is designed to meet the demand for materials in late-stage clinical trials and the potential commercial launch of BlueRock Therapeutics' bemdaneprocel (BRT-DA01), an investigational cell therapy under assessment for Parkinson's disease treatment. The establishment of the cutting-edge facility underscores Bayer's commitment to advancing cell therapies on a global scale and signifies a significant investment in the future of innovative medical solutions.

Government Initiatives

Governments around the globe are collaborating with major companies to stimulate the growth of the global cell therapy market. These partnerships aim to leverage governmental support and expertise to advance research, development, and accessibility of cell therapies. By fostering such collaborations, policymakers seek to create a conducive environment for innovation, accelerate regulatory approvals, and ensure widespread adoption of these advanced medical interventions. The synergy between governments and key industry players reflects a shared commitment to realize the full potential of cell therapies in revolutionizing healthcare and addressing challenges on a global scale.

In September 2023, the United States government unveiled new measures as part of the Cancer Moonshot Initiative, a focal point in the battle against cancer. The initiative was led by President through the collaborative entity "CancerX," aiming to reduce the U.S. cancer death rate by 50% before 2047. The initiative includes prominent pharmaceutical companies and their partnership with digital healthcare solution providers such as Amazon and Intel. The Moffitt Cancer Center in Florida and the Digital Medicine Society (DiMe), a global non-profit of digital medicine experts, lead the effort.

Growing Demand for T-Cell Therapy

The global cell therapy market is witnessing a growing demand for T-cell therapy. The innovative approach has gained prominence due to its remarkable success in treating certain cancers, especially hematologic malignancies. As clinical trials demonstrate its efficacy and safety, the demand for T-cell therapy is increasing. Patients, healthcare providers, and pharmaceutical companies recognize its potential to revolutionize cancer treatment by leveraging the body's immune system. The increasing demand is propelling research, development, and investment in T-cell therapies, contributing to the dynamic growth of global cell therapy market.

In March 2023, Thermo Fisher Scientific and Arsenal Biosciences, Inc., American companies, announced their strategic partnership to advance the manufacturing processes for novel cancer treatments. The collaboration emphasizes research and process development to establish a robust manufacturing framework for their cutting-edge, programmable autologous T cells designed for cancer treatment.

Future Market Scenario

The global cell therapy market is poised for a promising future, driven by a convergence of factors highlighting its potential to revolutionize healthcare. Advancements in cell therapy technologies, including precision-enhancing techniques like CRISPR gene editing, are increasing the efficacy and scope of treatments. The rising prevalence of chronic diseases, such as cancer and autoimmune disorders, create a compelling need for innovative therapeutic solutions, positioning cell therapy at the forefront of medical breakthroughs. Collaborative partnerships between pharmaceutical companies, biotech firms, and academic institutions are accelerating research and development efforts, fostering a dynamic environment of innovation. Supportive regulatory frameworks and increasing stakeholder awareness contribute towards a favorable landscape for the market's growth. With expanding applications across diverse medical domains and a global commitment to addressing unmet healthcare needs, the cell therapy market is poised to play a pivotal role in shaping the future of healthcare.

Key Players Landscape and Outlook

Numerous major companies are actively forming collaborations in the global cell therapy market. These strategic partnerships facilitate the pooling of resources, expertise, and technologies to drive innovation and expedite the development of advanced cell-based therapies. By joining forces, these companies enhance their capabilities in research, clinical trials, and manufacturing processes, ultimately contributing to the evolution and expansion of the cell therapy market.

For instance, in August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. unveiled a strategic investment to bolster Poseida's pioneering efforts in redefining cancer cell therapy. In the financial arrangement, Astellas is set to invest a total of USD 50 million, comprising a USD 25 million acquisition of 8,333,333 shares of Poseida's common stock (representing around 8.8% of the total outstanding common stock) at USD 3.00 per share through a private placement. Additionally, a one-time payment of USD 25 million secures Astellas an exclusive negotiation and first refusal right to license Poseida's clinical stage program, P-MUC1C-ALLO1. The program involves the development of an allogeneic CAR-T cell therapy targeting multiple solid tumor indications.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Cell Therapy Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
4.2. By Therapy Types
- 4.2.1. Allogenic Therapies
- 4.2.2. Autologous Therapies
4.3. By Cell Type
- 4.3.1. Stem Cell
- 4.3.2. Non-Stem Cell
4.4. By Product
- 4.4.1. Media, Sera, and Reagents
- 4.4.2. Cell Engineering Products
- 4.4.3. Cell Culture Vessels
- 4.4.4. Cell Therapy Equipment
- 4.4.5. System and Software
- 4.4.6. Other Products
4.5. By Application
- 4.5.1. Cardiovascular
- 4.5.2. Musculoskeletal
- 4.5.3. Oncology
- 4.5.4. Dermatology
- 4.5.5. Others
4.6. By End-users
- 4.6.1. Hospitals and Clinics
- 4.6.2. Biopharmaceutical and Biotech Companies
- 4.6.3. Academic and Research Institutes
- 4.6.4. Others
4.7. By Region
- 4.7.1. North America
- 4.7.2. Europe
- 4.7.3. South America
- 4.7.4. Asia-Pacific
- 4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023

5. Global Cell Therapy Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. Value
  - 5.1.1.2. Volume
- 5.1.2. By Therapy Types
  - 5.1.2.1. Allogenic Therapies
  - 5.1.2.2. Autologous Therapies
- 5.1.3. By Cell Type
  - 5.1.3.1. Stem Cell
  - 5.1.3.2. Non-Stem Cell
- 5.1.4. By Product
  - 5.1.4.1. Media, Sera, and Reagents
  - 5.1.4.2. Cell Engineering Products
  - 5.1.4.3. Cell Culture Vessels
  - 5.1.4.4. Cell Therapy Equipment
  - 5.1.4.5. System and Software
  - 5.1.4.6. Other Products
- 5.1.5. By Application
  - 5.1.5.1. Cardiovascular
  - 5.1.5.2. Musculoskeletal
  - 5.1.5.3. Oncology
  - 5.1.5.4. Dermatology
  - 5.1.5.5. Others
- 5.1.6. By End-users
  - 5.1.6.1. Hospitals and Clinics
  - 5.1.6.2. Biopharmaceutical and Biotech Companies
  - 5.1.6.3. Academic and Research Institutes
  - 5.1.6.4. Others
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
  - 5.1.7.1.1. Value
  - 5.1.7.1.2. Volume
  - 5.1.7.2. By Therapy Types
  - 5.1.7.2.1. Allogenic Therapies
  - 5.1.7.2.2. Autologous Therapies
  - 5.1.7.3. By Cell Type
  - 5.1.7.3.1. Stem Cell
  - 5.1.7.3.2. Non-Stem Cell
  - 5.1.7.4. By Product
  - 5.1.7.4.1. Media, Sera, and Reagents
  - 5.1.7.4.2. Cell Engineering Products
  - 5.1.7.4.3. Cell Culture Vessels
  - 5.1.7.4.4. Cell Therapy Equipment
  - 5.1.7.4.5. System and Software
  - 5.1.7.4.6. Other Products
  - 5.1.7.5. By Application
  - 5.1.7.5.1. Cardiovascular
  - 5.1.7.5.2. Musculoskeletal
  - 5.1.7.5.3. Oncology
  - 5.1.7.5.4. Dermatology
  - 5.1.7.5.5. Others
  - 5.1.7.6. By End-users
  - 5.1.7.6.1. Hospitals and Clinics
  - 5.1.7.6.2. Biopharmaceutical and Biotech Companies
  - 5.1.7.6.3. Academic and Research Institutes
  - 5.1.7.6.4. Others
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered:

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Therapy Type
6.2. By Cell Type
6.3. By Product
6.4. By Application
6.5. By End-users
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Thermo Fisher Scientific Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Merck KGaA
13.3. AstraZeneca plc
13.4. Astellas Pharma Inc.
13.5. Danaher Corporation
13.6. Sanofi S.A.
13.7. Becton, Dickinson and Company
13.8. Lonza Group
13.9. Novartis AG
13.10. Fresenius Medical Care AG & Co. KGaA
13.11. Avantor, Inc.
13.12. Bio-Techne Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

細胞治療市場の機会および予測 (2017-2031年)：治療タイプ・細胞タイプ・製品タイプ・用途・エンドユーザー・地域別

Cell Therapy Market Assessment, By Therapy Type, By Cell Type, By Product, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F

慢性疾患の有病率の上昇

最新の細胞治療ソリューションの開発に向けた投資の拡大

政府の取り組み

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の細胞治療市場の展望

第5章 世界の細胞治療市場の見通し：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組み・イノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 当社について・免責事項